We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Next Generation Automation Solution Exhibited at AACC

By Christina Chang, LabMedica Regional Director
Posted on 15 Jul 2013
Print article
AACC 2012: A new, adaptable automation solution allows a phased implementation to accommodate both current and future needs of medium- to very high-volume laboratories. The solution was unveiled at the 2012 annual meeting of the AACC and ASCLS and Clinical Lab Expo in Los Angeles (CA, USA) on July 15–19, 2012.

The circular track and modular design ensure Siemens Aptio Automation solution can adapt to nearly any lab or testing environment. It also offers connectivity to Siemens’ (Munich, Germany) portfolio of automation-ready analyzers, facilitating a multidisciplinary approach to testing. In addition, Aptio Automation’s point-in-space aspiration feature helps workflow by reducing the need to aliquot samples, and its puck-based system with Radio-frequency identification (RFID) enables individual sample routing and tracking, along with STAT prioritization.

William Bartlett, PhD, Joint Clinical Director of Diagnostics at the UK’s NHS Tayside (Dundee, United Kingdom) one of the first laboratories to deploy Aptio Automation, said: “We chose Aptio Automation because it can handle increasing workloads while enabling us to use our staff better. We expect that the implementation of this new platform will allow us to provide a state-of-the-art service that aligns the lab function with Tayside’s overall goals for organizational sustainability and improved patient outcomes.”

Today clinical laboratories are turning to automation to help them meet the growing demand for in vitro diagnostic testing as the labor force declines. And, these trends are only expected to continue, as approximately 17 % of laboratory professionals are anticipated to retire in the next five years. Aptio Automation is an adaptable solution that allows for a phased implementation to accommodate both current and future needs of labs.

Related Links:
Siemens
NHS Tayside


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.